Jpmorgan Chase & CO Clearside Biomedical, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 9,980 shares of CLSD stock, worth $39,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,980

Previous 10,358 3.65%

Holding current value

$39,920

Previous $10,000 10.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$0.79 - $1.13 $298 - $427	-378 Reduced 3.65%	9,980 $9,000
Q4 2024 Feb 12, 2025	SELL	$0.87 - $1.58 $5 - $9	-6 Reduced 0.06%	10,358 $10,000
Q3 2024 Dec 26, 2024	SELL	$0.93 - $1.35 $51 - $74	-55 Reduced 0.53%	10,364 $13,000
Q3 2024 Nov 08, 2024	SELL	$0.93 - $1.35 $51 - $74	-55 Reduced 0.53%	10,364 $13,000
Q2 2024 Dec 26, 2024	BUY	$1.08 - $1.58 $59 - $86	55 Added 0.53%	10,419 $13,000
Q2 2024 Aug 12, 2024	SELL	$1.08 - $1.58 $179 - $262	-166 Reduced 1.57%	10,419 $13,000
Q1 2024 Dec 26, 2024	BUY	$1.2 - $2.02 $265 - $446	221 Added 2.13%	10,585 $16,000
Q1 2024 May 10, 2024	BUY	$1.2 - $2.02 $8,851 - $14,899	7,376 Added 229.85%	10,585 $16,000
Q4 2023 Dec 26, 2024	SELL	$0.68 - $1.18 $4,865 - $8,442	-7,155 Reduced 69.04%	3,209 $3,000
Q4 2023 Feb 12, 2024	BUY	$0.68 - $1.18 $18 - $31	27 Added 0.85%	3,209 $3,000
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.27 $733 - $1,136	-895 Reduced 21.95%	3,182 $2,000
Q2 2023 Aug 11, 2023	BUY	$0.97 - $1.48 $929 - $1,417	958 Added 30.71%	4,077 $4,000
Q1 2023 May 11, 2023	SELL	$0.93 - $1.66 $10,002 - $17,853	-10,755 Reduced 77.52%	3,119 $3,000
Q4 2022 Feb 13, 2023	BUY	$1.0 - $1.5 $2,736 - $4,104	2,736 Added 24.56%	13,874 $15,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $7,584 - $12,852	-7,023 Reduced 38.67%	11,138 $12,000
Q2 2022 Aug 11, 2022	BUY	$1.3 - $2.49 $11,841 - $22,681	9,109 Added 100.63%	18,161 $27,000
Q1 2022 May 11, 2022	BUY	$1.35 - $2.88 $2,419 - $5,160	1,792 Added 24.68%	9,052 $21,000
Q4 2021 Feb 10, 2022	BUY	$2.72 - $5.72 $14,307 - $30,087	5,260 Added 263.0%	7,260 $20,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $7.2 $9,660 - $14,400	2,000 New	2,000 $12,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

11.6M

Call Options Held

Put Options Held

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $241M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Clearside Biomedical, Inc. Transaction History